Loading stock…

Argan, Inc. (AGX) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Argan, Inc.

AGXMarket cap $5.67BPrice $404.4

Country🇺🇸United States

SectorIndustrials

IndustryConstruction & Engineering

Builds power plants and industrial facilities, specializing in natural gas-fired generation that keeps America's grid running. This small-cap builder has ridden the AI-driven electricity boom, with its stock surging as data centers demand more power than utilities can supply.

In Bastion Portfolios?

52W Return+43%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+28%10

Revenue Forecast

Rev CAGR (1y)+48%10

Rev CAGR (3y)+26%9

Rev CAGR (5y)+11%8

Earnings Forecast

EPS Growth Y+1+32%9

EPS Growth Y+2+31%9

EPS Growth Y+3+7%6

Quality

Margins

EBIT Margin15%6

Net Income Margin15%7

Free Cash Flow Margin46%10

Debt

Net Debt/EBITDA-5.010

Efficiency

ROE40%10

ROA16%10

Earnings Stability77

GEAR+VERY STRONG87

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)292

P/E Ratio (Forward 3y)222

P/BV11.21

EV Multiples

EV/EBITDA Fwd192

EV/EBIT Fwd233

Yield

Free Cash Flow Yield9.6%9

Dividend Yield0.7%2

Momentum

Short term

1 month return-7%4

3 month return-39%1

YTD return+29%8

Mid term

Price vs 52wHigh50%1

1 year return+44%9

Long term

3 year return+783%10

5 year return+909%10

Risk Shield

Price Risk

Beta1.32

Volatility77%1

Free Cash Flow

Free Cash Flow Margin46%10

Free Cash Flow Yield9.6%9

Quality

ROCE40%10

Earnings Stability77

Net Debt/EBITDA-5.010

02Growth

Is it actually growing, and how fast?

AGXArgan

Revenue FY26$945M

GROWTH RATING↗

VERY STRONG92 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+28%10

Revenue, next 1Y+48%10

Revenue, next 3Y, CAGR+26%9

Revenue, next 5Y, CAGR+11%8

EARNINGS FORECAST▾SCORE

EPS growth, FY27E+32%9

EPS growth, FY28E+31%9

EPS growth, FY29E+7%6

GROWTH ASSESSMENT

STRENGTHS

It out-grows 92% of companies worldwide.

Revenue grew 28%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 26%/yr over the next 3 years, ahead of most of the market.9/10

Revenue grew 28%/yr over the last 3 years and is set to keep growing around 26%/yr.

The runway holds up: revenue is set to grow 11%/yr over five years.8/10

Earnings are set to grow faster than sales (EPS about 31%/yr vs revenue 26%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE45 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-7%4

3-month return-39%1

YTD return+29%8

MID & LONG-TERM▾SCORE

% of 52-week high50%1

1-year return+44%9

3-year return+783%10

5-year return+909%10

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +783% over three years and +909% over five, ahead of 90% of the market.

Strong recent results. The stock is outperforming so far this year (+29%).

WATCH

It's up 44% over the past year, but 50% below its 52-week high. That is right in line with the market.

Returns sit at the market level over the past month (-7%).

WEAKNESSES

The stock is underperforming over three months (-39%).

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout. The one thing to watch: the stock is underperforming over three months.

04Value

Are you paying a fair price for it?

Stop guessing on Argan, Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

AGXArgan

Revenue FY26$945M

GROWTH RATING↗

VERY STRONG92 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+28%10

Revenue, next 1Y+48%10

Revenue, next 3Y, CAGR+26%9

Revenue, next 5Y, CAGR+11%8

EARNINGS FORECAST▾SCORE

EPS growth, FY27E+32%9

EPS growth, FY28E+31%9

EPS growth, FY29E+7%6

GROWTH ASSESSMENT

STRENGTHS

It out-grows 92% of companies worldwide.

Revenue grew 28%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 26%/yr over the next 3 years, ahead of most of the market.9/10

Revenue grew 28%/yr over the last 3 years and is set to keep growing around 26%/yr.

The runway holds up: revenue is set to grow 11%/yr over five years.8/10

Earnings are set to grow faster than sales (EPS about 31%/yr vs revenue 26%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE45 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-7%4

3-month return-39%1

YTD return+29%8

MID & LONG-TERM▾SCORE

% of 52-week high50%1

1-year return+44%9

3-year return+783%10

5-year return+909%10

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +783% over three years and +909% over five, ahead of 90% of the market.

Strong recent results. The stock is outperforming so far this year (+29%).

WATCH

It's up 44% over the past year, but 50% below its 52-week high. That is right in line with the market.

Returns sit at the market level over the past month (-7%).

WEAKNESSES

The stock is underperforming over three months (-39%).

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout. The one thing to watch: the stock is underperforming over three months.

04Value

Are you paying a fair price for it?

Stop guessing on Argan, Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community